| Literature DB >> 10772714 |
V R Hegde1, K L Seley, S W Schneller.
Abstract
A convenient preparation of (1'R,2'S,3'R,4'S)-1-(2',3',4'-trihydroxycyclopent-1'-yl)-1H-uracil (carbocyclic 5'-noruridine, 1) is described in 2 steps from the palladium complex of (+)-(1R,4S)-4-hydroxy-2-cyclopenten-1-yl acetate (3) and the sodium salt of uracil (2). Compound 1 was sought as a previously unknown member of the series of carbocyclic 5'-nor nucleosides needed as moieties for new oligomers. With 1 available, its antiviral properties and those of its enantiomer (5) are reported with 5 showing promising activity towards Epstein-Barr virus.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10772714 DOI: 10.1080/15257770008033008
Source DB: PubMed Journal: Nucleosides Nucleotides Nucleic Acids ISSN: 1525-7770 Impact factor: 1.381